• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[F]-FDG PET与支持向量机判别分析在肌萎缩侧索硬化症患者与对照自动分类中的多中心验证

Multicenter validation of [F]-FDG PET and support-vector machine discriminant analysis in automatically classifying patients with amyotrophic lateral sclerosis versus controls.

作者信息

D'hulst Ludovic, Van Weehaeghe Donatienne, Chiò Adriano, Calvo Andrea, Moglia Cristina, Canosa Antonio, Cistaro Angelina, Willekens Stefanie Ma, De Vocht Joke, Van Damme Philip, Pagani Marco, Van Laere Koen

机构信息

a Division of Nuclear Medicine and Department of Imaging and pathology , University Hospitals Leuven and KU Leuven , Leuven , Belgium.

b ALS Center, 'Rita Levi Montalcini' Department of Neuroscience , University of Torino , Torino , Italy.

出版信息

Amyotroph Lateral Scler Frontotemporal Degener. 2018 Nov;19(7-8):570-577. doi: 10.1080/21678421.2018.1476548. Epub 2018 Jun 4.

DOI:10.1080/21678421.2018.1476548
PMID:29862846
Abstract

OBJECTIVE

F-Fluorodeoxyglucose (F-FDG) positron emission tomography (PET) single-center studies using support vector machine (SVM) approach to differentiate amyotrophic lateral sclerosis (ALS) from controls have shown high overall accuracy on an individual patient basis using local a priori defined classifiers. The aim of the study was to validate the SVM accuracy on a multicentric level.

METHODS

A previously defined Belgian (BE) group of 175 ALS patients (61.9 ± 12.2 years, 120M/55F) and 20 screened healthy controls (62.4 ± 6.4 years, 12M/8F) was used to classify another large dataset from Italy (IT), consisting of 195 patients (63.2 ± 11.6 years, 117M/78F) and 40 controls (62 ± 14.4 years; 29M/11F) free of any neurological and psychiatric disorder who underwent whole-body F-FDG PET-CT for lung cancer without any evidence of paraneoplastic symptoms. F-FDG within-center group comparisons based on statistical parametric mapping (SPM) were performed and SVM classifiers based on the local training sets were applied to differentiate ALS from controls from the other centers.

RESULTS

SPM group analysis showed only minor differences between both ALS groups, indicating pattern consistency. SVM using BE data set as training, classified 183/193 ALS-IT correctly (accuracy of 94.8%). However, 35/40 CON-IT were misclassified as ALS (accuracy 12.5%). Furthermore, using IT data as training, ALS-BE could not be distinguished from CON-BE. Within-center SPM group analysis confirmed prefrontal hypometabolism in CON-IT versus CON-BE, indicating subclinical brain changes in patients undergoing oncological scanning.

CONCLUSION

This multicenter study confirms that the F-FDG ALS pattern is stable across centers. Furthermore, it highlights the importance of carefully selected controls, as subclinical frontal changes might be present in patients in an oncological setting.

摘要

目的

采用支持向量机(SVM)方法区分肌萎缩侧索硬化症(ALS)与对照的F-氟脱氧葡萄糖(F-FDG)正电子发射断层扫描(PET)单中心研究表明,使用局部先验定义的分类器在个体患者层面具有较高的总体准确率。本研究的目的是在多中心层面验证SVM的准确性。

方法

先前定义的比利时(BE)组包括175例ALS患者(61.9± 12.2岁,120名男性/55名女性)和20名经过筛选的健康对照(62.4± 6.4岁,12名男性/8名女性),用于对来自意大利(IT)的另一个大型数据集进行分类,该数据集包括195例患者(63.2± 11.6岁,117名男性/78名女性)和40名对照(62± 14.4岁;29名男性/11名女性),这些对照无任何神经和精神疾病,因肺癌接受了全身F-FDG PET-CT检查,且无任何副肿瘤综合征症状的证据。基于统计参数映射(SPM)进行中心内F-FDG组间比较,并应用基于局部训练集的SVM分类器区分来自其他中心的ALS与对照。

结果

SPM组分析显示两个ALS组之间仅有微小差异,表明模式一致性。以BE数据集作为训练集的SVM正确分类了183/193例ALS-IT患者(准确率为94.8%)。然而,35/40例CON-IT被误分类为ALS(准确率12.5%)。此外,以IT数据作为训练集时,无法区分ALS-BE与CON-BE。中心内SPM组分析证实CON-IT与CON-BE相比存在前额叶代谢减低,表明接受肿瘤扫描的患者存在亚临床脑改变。

结论

这项多中心研究证实F-FDG ALS模式在各中心之间是稳定的。此外,它强调了精心选择对照的重要性,因为肿瘤患者可能存在亚临床额叶改变。

相似文献

1
Multicenter validation of [F]-FDG PET and support-vector machine discriminant analysis in automatically classifying patients with amyotrophic lateral sclerosis versus controls.[F]-FDG PET与支持向量机判别分析在肌萎缩侧索硬化症患者与对照自动分类中的多中心验证
Amyotroph Lateral Scler Frontotemporal Degener. 2018 Nov;19(7-8):570-577. doi: 10.1080/21678421.2018.1476548. Epub 2018 Jun 4.
2
Prospective Validation of 18F-FDG Brain PET Discriminant Analysis Methods in the Diagnosis of Amyotrophic Lateral Sclerosis.18F-FDG脑PET判别分析方法在肌萎缩侧索硬化症诊断中的前瞻性验证
J Nucl Med. 2016 Aug;57(8):1238-43. doi: 10.2967/jnumed.115.166272. Epub 2016 Mar 3.
3
Clinical relevance of single-subject brain metabolism patterns in amyotrophic lateral sclerosis mutation carriers.肌萎缩侧索硬化症突变携带者中单个体脑代谢模式的临床相关性。
Neuroimage Clin. 2022;36:103222. doi: 10.1016/j.nicl.2022.103222. Epub 2022 Oct 5.
4
Combined brain and spinal FDG PET allows differentiation between ALS and ALS mimics.脑部和脊髓联合氟代脱氧葡萄糖正电子发射断层扫描(FDG PET)可区分肌萎缩侧索硬化症(ALS)和疑似ALS的疾病。
Eur J Nucl Med Mol Imaging. 2020 Oct;47(11):2681-2690. doi: 10.1007/s00259-020-04786-y. Epub 2020 Apr 20.
5
Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis.脑 FDG-PET 在肌萎缩侧索硬化症中的功能模式。
Neurology. 2014 Sep 16;83(12):1067-74. doi: 10.1212/WNL.0000000000000792. Epub 2014 Aug 13.
6
Value of 18fluorodeoxyglucose-positron-emission tomography in amyotrophic lateral sclerosis: a prospective study.18 氟脱氧葡萄糖正电子发射断层扫描在肌萎缩侧索硬化症中的价值:一项前瞻性研究。
JAMA Neurol. 2014 May;71(5):553-61. doi: 10.1001/jamaneurol.2014.62.
7
Role of brain 2-[F]fluoro-2-deoxy-D-glucose-positron-emission tomography as survival predictor in amyotrophic lateral sclerosis.脑 2-[F]氟代-2-脱氧-D-葡萄糖正电子发射断层扫描在肌萎缩侧索硬化症中作为生存预测指标的作用。
Eur J Nucl Med Mol Imaging. 2023 Feb;50(3):784-791. doi: 10.1007/s00259-022-05987-3. Epub 2022 Oct 29.
8
Metabolic spatial connectivity in amyotrophic lateral sclerosis as revealed by independent component analysis.独立成分分析揭示的肌萎缩侧索硬化症中的代谢空间连通性
Hum Brain Mapp. 2016 Mar;37(3):942-53. doi: 10.1002/hbm.23078. Epub 2015 Dec 24.
9
Heterogeneous brain FDG-PET metabolic patterns in patients with C9orf72 mutation.携带 C9orf72 突变患者脑 FDG-PET 代谢的异质性模式。
Neurol Sci. 2019 Mar;40(3):515-521. doi: 10.1007/s10072-018-3685-7. Epub 2018 Dec 15.
10
Cerebral 18F-FDG PET in macrophagic myofasciitis: An individual SVM-based approach.巨噬细胞性肌炎的脑 18F-FDG PET:基于支持向量机的个体分析方法
PLoS One. 2017 Jul 13;12(7):e0181152. doi: 10.1371/journal.pone.0181152. eCollection 2017.

引用本文的文献

1
Sex-related differences in amyotrophic lateral sclerosis: A 2-[F]FDG-PET study.肌萎缩侧索硬化症的性别相关差异:一项2-[F]FDG-PET研究。
Eur J Neurol. 2025 Jan;32(1):e16588. doi: 10.1111/ene.16588.
2
Quantitative Brain MRI Metrics Distinguish Four Different ALS Phenotypes: A Machine Learning Based Study.定量脑磁共振成像指标可区分四种不同的肌萎缩侧索硬化症表型:一项基于机器学习的研究。
Diagnostics (Basel). 2023 Apr 24;13(9):1521. doi: 10.3390/diagnostics13091521.
3
Implications of Artificial Intelligence Algorithms in the Diagnosis and Treatment of Motor Neuron Diseases-A Review.
人工智能算法在运动神经元疾病诊断与治疗中的应用——综述
Life (Basel). 2023 Apr 17;13(4):1031. doi: 10.3390/life13041031.
4
Amyotrophic lateral sclerosis.肌萎缩性侧索硬化症。
Lancet. 2022 Oct 15;400(10360):1363-1380. doi: 10.1016/S0140-6736(22)01272-7. Epub 2022 Sep 15.
5
Simultaneous PET/MRI: The future gold standard for characterizing motor neuron disease-A clinico-radiological and neuroscientific perspective.同步正电子发射断层扫描/磁共振成像:用于表征运动神经元疾病的未来金标准——临床放射学和神经科学视角
Front Neurol. 2022 Aug 17;13:890425. doi: 10.3389/fneur.2022.890425. eCollection 2022.
6
Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis.肌萎缩侧索硬化症诊断与预后的最新进展
Lancet Neurol. 2022 May;21(5):480-493. doi: 10.1016/S1474-4422(21)00465-8. Epub 2022 Mar 22.
7
Drug Discovery of Spinal Muscular Atrophy (SMA) from the Computational Perspective: A Comprehensive Review.从计算角度看脊髓性肌萎缩症(SMA)的药物发现:全面综述。
Int J Mol Sci. 2021 Aug 20;22(16):8962. doi: 10.3390/ijms22168962.
8
Non-invasive characterization of amyotrophic lateral sclerosis in a hTDP-43 mouse model: A PET-MR study.TDP-43 突变型小鼠模型的非侵入性肌萎缩侧索硬化症特征分析:一项 PET-MR 研究。
Neuroimage Clin. 2020;27:102327. doi: 10.1016/j.nicl.2020.102327. Epub 2020 Jun 25.
9
Lifetime sport practice and brain metabolism in Amyotrophic Lateral Sclerosis.终身运动锻炼与肌萎缩侧索硬化症的大脑代谢。
Neuroimage Clin. 2020;27:102312. doi: 10.1016/j.nicl.2020.102312. Epub 2020 Jun 12.
10
Are Circulating Cytokines Reliable Biomarkers for Amyotrophic Lateral Sclerosis?循环细胞因子是否是肌萎缩侧索硬化症的可靠生物标志物?
Int J Mol Sci. 2019 Jun 5;20(11):2759. doi: 10.3390/ijms20112759.